Researcher profile
Marion LEBOYER
Affiliations
Organizations
Assistance Publique – Hôpitaux de Parisauthorship · FRCentre Hospitalier Charles Perrensauthorship · FRCentre Hospitalier Universitaire Henri-Mondorauthorship · FRCentre National de la Recherche Scientifiqueauthorship · FRFondation FondaMentalauthorship · FRHôpital Albert-Chenevierauthorship · FRHôpitaux Universitaires Henri-Mondorauthorship · FRInsermauthorship · FRInstitut de Neurosciences Cognitives et Intégratives d’Aquitaineauthorship · FRInstitut Mondor de Recherche Biomédicaleauthorship · FRUniversité de Bordeauxauthorship · FRUniversité Paris-Est Créteilauthorship · FR
Public evidence
2 connected articles
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open AccessThe contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.2019 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.